Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look ...

CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The ...

CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

CVS Health and its subsidiaries have experienced a turbulent week in the courts. | Not long after the state of Louisiana sued ...

CVS Health's pharmacy benefit manager unit must pay the U.S. government $95 million after a federal judge found it ...

This action was surfaced by Law.com Radar, which delivers real-time alerting on new litigation across more than 2,900 state ...

Shares of CVS Health are trading higher Thursday afternoon. The stock is climbing after a GOP healthcare bill hit a roadblock ...

Aetna Insurance Corp. investors should be able to resume their suit alleging CVS Health Corp. failed to disclose downsides ...

In the assessment of 12-month price targets, analysts unveil insights for CVS Health, presenting an average target of $79.0, ...